TB-500
Synthetic Fragment (17-23) of Thymosin Beta-4
A synthetic 7-amino acid fragment corresponding to the actin-binding region of thymosin beta-4, originally developed for equine use with retained tissue repair properties. TB-500 acts as principal actin-sequestering protein, regulating cell migration, promoting angiogenesis, reducing inflammation, and activating stem cell differentiation.
Mechanism of Action
Acts as principal actin-sequestering protein, regulating cell migration, promoting angiogenesis, reducing inflammation, and activating stem cell differentiation for comprehensive regenerative effects.
Key Benefits
- Superior systemic tissue repair
- Accelerated muscle, tendon, and ligament healing
- Enhanced cell migration and angiogenesis
- Comprehensive regenerative effects
- Neuroprotective properties
?SDKPDMAEIEKFDKSKLKKTETQEKNPLPSKETIEQEKQAGESAc
Position 1
Serine
Position 2
Aspartic Acid
Position 3
Lysine
Position 4
Proline
Position 5
Aspartic Acid
Position 6
Methionine
Position 7
Alanine
Position 8
Glutamic Acid
Position 9
Isoleucine
Position 10
Glutamic Acid
Position 11
Lysine
Position 12
Phenylalanine
Position 13
Aspartic Acid
Position 14
Lysine
Position 15
Serine
Position 16
Lysine
Position 17
Leucine
Position 18
Lysine
Position 19
Lysine
Position 20
Threonine
Position 21
Glutamic Acid
Position 22
Threonine
Position 23
Glutamine
Position 24
Glutamic Acid
Position 25
Lysine
Position 26
Asparagine
Position 27
Proline
Position 28
Leucine
Position 29
Proline
Position 30
Serine
Position 31
Lysine
Position 32
Glutamic Acid
Position 33
Threonine
Position 34
Isoleucine
Position 35
Glutamic Acid
Position 36
Glutamine
Position 37
Glutamic Acid
Position 38
Lysine
Position 39
Glutamine
Position 40
Alanine
Position 41
Glycine
Position 42
Glutamic Acid
Position 43
Serine
Position 44
Tissue Repair
- Muscle Regeneration
Accelerated healing of muscle fibers with reduced recovery time and enhanced repair via cell migration and differentiation.
- Tendon & Ligament Healing
Connective tissue repair with reduced scar formation and improved biomechanical properties of healing tissues.
- Wound Healing
Enhanced dermal closure, improved angiogenesis, and reduced inflammation in acute and chronic scenarios.
Athletic Recovery
- Exercise Recovery
Faster recovery from intense training with reduced muscle soreness and improved tissue repair.
- Injury Prevention
Strengthened tissues through enhanced repair mechanisms may reduce injury risk.
- Performance Enhancement
Improved muscle quality through enhanced regeneration and repair pathways.
Neurological
- Neuroprotection
Protective effects against neuronal damage in various models.
- Spinal Cord Injury Support
Preclinical evidence for improved outcomes in spinal injury models.
- Brain Health
Potential neuroprotective and regenerative effects on brain tissue.
Subcutaneous or intramuscular injection. Flexible timing with no empty stomach requirement. Can be injected near injury site for localized effect.
| Goal | Dose | Frequency | Route |
|---|---|---|---|
| General tissue repair | 2-3mg | 2x weekly | SubQ or IM |
| Serious injury recovery | 4-5mg | 3x weekly | SubQ near injury site |
| Athletic enhancement | 2-3mg | 2x weekly | SubQ |
| Chronic conditions | 3-4mg | 2-3x weekly | SubQ or IM |
| Maintenance | 2mg | 1-2x weekly | SubQ |
| Post-surgical recovery | 3-5mg | 3x weekly | SubQ |
Reconstitution Instructions
- Bacteriostatic water (BAC)
- Insulin syringes (1mL recommended)
- Alcohol swabs
- TB-500 vial (2mg or 5mg typical)
- Sterile work surface
- 1 Clean work area and hands thoroughly with alcohol
- 2 Calculate required BAC water volume
- 3 Draw calculated BAC water slowly into syringe
- 4 Inject BAC water slowly down vial side (never directly on powder)
- 5 Gently swirl vial until powder completely dissolves
- 6 Store reconstituted solution refrigerated, use within 28 days
Complementary healing mechanisms with enhanced tissue repair when combined (Wolverine Stack).
May enhance tissue sensitivity to growth hormone effects.
Combined tissue repair with GH-releasing effects for comprehensive recovery.
Enhanced muscle and tissue regeneration through complementary growth pathways.
No negative interactions; potential enhanced recovery.
Different receptor families with no pathway overlap.
Reduced inflammation and improved tissue sensation
Accelerated healing rate and improved tissue quality
Maximum tissue repair and regenerative benefits
Continued improvement in tissue strength and function
Common Side Effects
- Generally minimal side effects
- Possible mild injection site reactions
- Temporary fatigue in some users
Stop Signs - Discontinue if:
- Persistent or worsening injection site infections
- Unusual swelling or prolonged redness
- Severe allergic reactions
- Unexpected systemic symptoms
- Concerning health changes
Contraindications
- Active cancer treatment (due to angiogenic effects)
- Pregnancy or breastfeeding
- Immunosuppressive medications (consult provider)
- WADA prohibited for competitive athletes
Good Signs
- White lyophilized powder - fine, evenly distributed with light fluffy texture
- Clear, colorless solution after reconstitution with no particles
- Proper vacuum seal intact with secure rubber stopper
Warning Signs
- Slight powder clumping acceptable if completely dissolves with gentle swirling
Bad Signs
- Colored or crystalline powder (yellow/brown indicates degradation)
- Persistent cloudiness, floating particles, or precipitation
- Damaged vial seal or contamination signs
- Dermal Wound Healing Study(2012)
Significant acceleration in wound healing rates in patients with chronic pressure ulcers and venous stasis ulcers compared to placebo in Phase 2 human trial.
- Cardiac Tissue Regeneration(2016)
TB-500 pre-treated endothelial cells improved left ventricular function by greater than 50% in post-MI subjects in human clinical trial.
- Muscle Fiber Regeneration(2015)
Improved skeletal muscle fiber regeneration in dystrophin-deficient mice, showing potential for muscular dystrophy treatment.
- Corneal Healing Research(2014)
Topical TB-500 significantly improved signs and symptoms of moderate to severe dry eye with lasting effects in Phase 2 human trial.
Disclaimer
This information is for educational and research purposes only. Consult a healthcare professional before use.